Hologic Rejects $16B Buyout, Shares Surge

Hologic Inc.'s stock rose 14% after private equity firms TPG and Blackstone made a nonbinding buyout offer exceeding $16 billion, valuing the company's shares at $70 to $72, about a 30% premium over the previous close. Hologic rejected the offer, but investors remain optimistic about the possibility of renewed negotiations. The interest from TPG and Blackstone underscores strong private equity interest in the medical technology sector. Blackstone's own share price also rose moderately following news of the acquisition talks. Analysts note potential operational risks for Blackstone in executing such a large transaction, and both companies have declined to comment on the matter. The outcome of any future negotiations could significantly influence the valuation and strategic direction of both firms.